Rare T-box variants in adult pulmonary arterial hypertension with congenital heart disease

被引:0
|
作者
Li, Li [1 ]
Chen, Guoliang [2 ]
Qiao, Nating [3 ]
Li, Jianwei [4 ]
Wang, Zhixin [1 ]
Lyu, Yaxuan [1 ]
Guo, Yanqing [1 ,3 ]
机构
[1] Shanxi Med Univ, Shanxi Cardiovasc Hosp, Precis Lab Vasc Med, Taiyuan 030024, Peoples R China
[2] Shanxi Med Univ, Shanxi Cardiovasc Hosp, Dept Cardiac Surg, Taiyuan 030024, Peoples R China
[3] Shanxi Med Univ, Shanxi Cardiovasc Hosp, Dept Cardiol, Taiyuan 030024, Peoples R China
[4] Shanxi Med Univ, Shanxi Cardiovasc Hosp, Cent Lab, Taiyuan 030024, Peoples R China
关键词
T-box; Pulmonary arterial hypertension; Congenital heart disease; Variants; HOLT-ORAM-SYNDROME; TBX4; MUTATIONS; BUD FORMATION; GENES; EXPRESSION; TETRALOGY;
D O I
10.1007/s13353-025-00958-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We report the clinical and genetic features of three adult patients with congenital heart disease-associated pulmonary arterial hypertension (CHD-PAH) carrying rare T-box variants. All three patients had weakness and cyanosis. Two patients had chest tightness, dry cough, and hemoptysis, and one patient had lower limb edema. Besides meeting the diagnostic criteria of CHD-PAH, three patients respectively presented the clinical features of specific syndromes. Specifically, patient 1 presented with clinical features consistent with tetralogy of Fallot, patient 2 presented with characteristics associated with small patella syndrome, and the patient 3 exhibited features consistent with Holt-Oram syndrome. Exome sequencing revealed that the TBX1 (c.820 T > C) variant was identified in patient 1, the TBX4 (c.251del) variant was detected in patient 2 and the TBX5 (c.486del) variant was found in patient 3. Our study for the first time found that CHD-PAH patients carry T-box gene variants, which has added new clues to understanding the pathogenesis of CHD-PAH and is expected to provide new targets and ideas for the diagnosis and treatment of CHD-PAH.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Congenital heart disease and pulmonary arterial hypertension in South America
    Lopes, Antonio Augusto
    Flores, Patricia C.
    Diaz, Gabriel F.
    Mesquita, Sonia M. F.
    PULMONARY CIRCULATION, 2014, 4 (03) : 370 - 377
  • [32] The epidemiology of pulmonary arterial hypertension in patients with congenital heart disease
    Sun, Yun-Juan
    Pang, Kun-Jing
    Zeng, Wei-Jie
    Wang, Hao
    He, Jian-Guo
    CARDIOLOGY, 2011, 120 : 9 - 9
  • [33] Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
    Ramjug, Sheila
    Billings, Catherine
    Bowater, Sarah
    Charalampopoulos, Athanasios
    Clift, Paul
    Elliot, Charlie
    Hurdman, Judith
    Jenkins, Petra
    Kiely, David
    Lewis, Robert
    Oliver, James
    Sabroe, Ian
    Condliffe, Robin
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [34] Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease
    van der Feen, Diederik E.
    Bartelds, Beatrijs
    de Boer, Rudolf A.
    Berger, Rolf M. F.
    HEART, 2019, 105 (04) : 276 - 282
  • [35] Ambrisentan for Pulmonary Arterial Hypertension Due to Congenital Heart Disease
    Zuckerman, Warren A.
    Leaderer, Derek
    Rowan, Cherise A.
    Mituniewicz, Johnell D.
    Rosenzweig, Erika Berman
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (09): : 1381 - 1385
  • [36] Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease
    Favoccia, Carla
    Constantine, Andrew H.
    Wort, Stephen J.
    Dimopoulos, Konstantinos
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (06) : 449 - 459
  • [37] Riociguat for pulmonary arterial hypertension associated with congenital heart disease
    Rosenkranz, Stephan
    Ghofrani, Hossein-Ardeschir
    Beghetti, Maurice
    Ivy, Dunbar
    Frey, Reiner
    Fritsch, Arno
    Weimann, Gerrit
    Saleh, Soundos
    Apitz, Christian
    HEART, 2015, 101 (22) : 1792 - U41
  • [38] From bosentan to macitentan for pulmonary arterial hypertension and adult congenital heart disease: Further improvement?
    Blok, Ilja M.
    van Riel, Annelieke C. M. J.
    van Dijk, Arie P. J.
    Mulder, Barbara J. M.
    Bouma, Berto J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 51 - 52
  • [39] Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease
    Cheng, Xiao-Ling
    Liu, Zhi-Hong
    Gu, Qing
    Ni, Xin-Hai
    Luo, Qin
    Zhao, Zhi-Hui
    He, Jian-Guo
    Xiong, Chang-Ming
    INTERNATIONAL HEART JOURNAL, 2017, 58 (05) : 731 - 738
  • [40] PHYSIOLOGICAL STUDIES IN CONGENITAL HEART DISEASE .7. PULMONARY ARTERIAL HYPERTENSION IN CONGENITAL HEART DISEASE
    GRISWOLD, HE
    BING, RJ
    HANDELSMAN, JC
    CAMPBELL, JA
    LEBRUN, E
    BULLETIN OF THE JOHNS HOPKINS HOSPITAL, 1949, 84 (01): : 76 - 88